Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  56,000 results for ""Antirheumatic Agents""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study.

  • Authors : Shih PC; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, No. 135, NanXiao Street, Changhua, 500, Taiwan. .; Institute of Medicine, Chung Shan Medical University, South District, No. 110, Sec. 1, Jianguo N. Rd., Taichung, 40201, Taiwan. .

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Pyrimidines*/Pyrimidines*/Pyrimidines*/therapeutic use ; Pyrimidines*/Pyrimidines*/Pyrimidines*/administration & dosage

  • Source: Clinical rheumatology [Clin Rheumatol] 2024 Dec; Vol. 43 (12), pp. 3625-3637. Date of Electronic Publication: 2024 Oct 11.Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.

  • Authors : Buch MH; Centre for Musculoskeletal Research, University of Manchester, Manchester, UK .; NIHR Manchester Biomedical Research Centre, Manchester, UK.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects

  • Source: RMD open [RMD Open] 2024 Oct 24; Vol. 10 (4). Date of Electronic Publication: 2024 Oct 24.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment.

  • Authors : Feist E; Rheumatology and Clinical Immunology, HELIOS Fachklinik Vogelsang/Gommern, Vogelsang, Germany .; Experimental Rheumatology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Subjects: Methotrexate*/Methotrexate*/Methotrexate*/therapeutic use ; Methotrexate*/Methotrexate*/Methotrexate*/adverse effects ; Methotrexate*/Methotrexate*/Methotrexate*/administration & dosage

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1454-1464. Date of Electronic Publication: 2024 Oct 21.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis.

  • Authors : Gladman DD; Department of Medicine, University of Toronto, and Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, 399 Bathurst St. 1E-411, Toronto, ON, M5T 2S8, Canada. .; Nash P

Subjects: Pyrimidines*/Pyrimidines*/Pyrimidines*/therapeutic use ; Pyrimidines*/Pyrimidines*/Pyrimidines*/adverse effects ; Pyrimidines*/Pyrimidines*/Pyrimidines*/administration & dosage

  • Source: Arthritis research & therapy [Arthritis Res Ther] 2024 Dec 19; Vol. 26 (1), pp. 218. Date of Electronic Publication: 2024 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362

Record details

Read More Add to Saved list
×
Academic Journal

[Application status of methotrexate in patients with rheumatoid arthritis].

  • Authors : Han Y; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.; Chen X

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Methotrexate*/Methotrexate*/Methotrexate*/administration & dosage ; Methotrexate*/Methotrexate*/Methotrexate*/therapeutic use

  • Source: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2024 Dec 18; Vol. 56 (6), pp. 994-1000.Publisher: Beijing da xue Country of Publication: China NLM ID: 101125284 Publication Model: Print Cited Medium: Print ISSN: 1671-167X (Print)

Record details

Read More Add to Saved list
×
Academic Journal

New onset heart failure in adolescents with inflammatory joint disease treated with TNF-α inhibitors: a case-based review.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/chemically induced ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy

  • Source: Rheumatology international [Rheumatol Int] 2024 Dec 18; Vol. 45 (1), pp. 4. Date of Electronic Publication: 2024 Dec 18.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report].

  • Authors : Ma D; Department of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China.; Lu Z

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Rituximab*/Rituximab*/Rituximab*/therapeutic use

  • Source: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2024 Dec 18; Vol. 56 (6), pp. 1110-1114.Publisher: Beijing da xue Country of Publication: China NLM ID: 101125284 Publication Model: Print Cited Medium: Print ISSN: 1671-167X (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity.

  • Authors : Ramsay H; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Johnston RV

Subjects: Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/administration & dosage

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Dec 16; Vol. 12. Cochrane AN: CD015880. Date of Electronic Publication: 2024 Dec 16.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

Read More Add to Saved list
×
Academic Journal

Potential mechanisms of rheumatoid arthritis therapy: Focus on macrophage polarization.

  • Authors : Yang X; College of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, China.; Li J

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/immunology ; Macrophages*/Macrophages*/Macrophages*/immunology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Dec 05; Vol. 142 (Pt A), pp. 113058. Date of Electronic Publication: 2024 Sep 04.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mimickers of hydroxychloroquine retinal toxicity.

  • Authors : Jones P; UPMC Vision Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Kalra G

Subjects: Hydroxychloroquine*/Hydroxychloroquine*/Hydroxychloroquine*/adverse effects ; Retinal Diseases*/Retinal Diseases*/Retinal Diseases*/chemically induced ; Retinal Diseases*/Retinal Diseases*/Retinal Diseases*/diagnosis

  • Source: Clinical & experimental ophthalmology [Clin Exp Ophthalmol] 2024 Dec; Vol. 52 (9), pp. 1003-1015. Date of Electronic Publication: 2024 Dec 03.Publisher: Wiley-Blackwell Pub. Asia Country of Publication: Australia NLM ID: 100896531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  56,000 results for ""Antirheumatic Agents""